retatrutide triple agonist glp-1 gip glucagon phase 2 results π¨ Today, retatrutide, the GIP/GLP-1/glucagon agonist, just delivered TRIUMPH-2 top-line results. A study in those with concurrent obesity and type diabetes. π Mean body weight change at 80 weeks: β¬οΈ Retatrutide: The GLP-1/GIP/Glucagon Triple-Agonist Guide
Pay in 4 interest-free payments of $5.44 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours Β· Estimated delivery Nov 4 - Nov 9








![Is Zepbound the Same as Ozempic? Key Differences Explained [2026]](https://instantuc.com/wp-content/uploads/2026/04/Zepbound-vs.-Ozempic-Mechanism-and-Efficacy-Comparison-2026-1024x559.png)







:max_bytes(150000):strip_icc()/Health-GettyImages-2190382180-5fb9712447fa4ce29876665304bbe000.jpg)









